Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY ® (pertuzumab) 420 mg/14 mL injection for ...
GeoVax CEO David Dodd highlights the need for U.S. manufacturing to reduce reliance on foreign biotech and strengthen ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
Carbios (Euronext Growth Paris: ALCRB) announces to its shareholders and the financial community that its 2025 Universal Registration Document, including: the 2025 annual report, comprising the ...
Globevisa analyzes how Dominica's 33-year CBI program provides HNWIs with constitutional reliability and economic ...
On April 16, Morgan Stanley increased the price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) from $50 to $67, ...
Laguna Biotherapeutics, Inc. (Laguna), a clinical-stage biotechnology company focused on novel live bacterial therapeutics, ...
Laguna Biotherapeutics, Inc. (Laguna), a clinical-stage biotechnology company focused on novel live bacterial therapeutics, ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced today that it has entered ...
Mesoblast shares (ASX:MSB) jumped today after the regenerative medicine company announced full patient enrollment in its pivotal Phase 3 trial for chronic low back pain, clearing a critical execution ...
Tools such as single-cell sequencing — akin to a microscopic detective tracking what happens inside each infected cell — and ...
Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results